|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00775 CKLIFE SCIENCES
Nominal 
0.930 0.000 (0.000%) | 2025/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | |
| Turnover | 2,605,812 | -1.140% | 5,522,674 | 5,322,733 | 5,275,590 | 5,402,312 |
| Cost of Sales | (1,812,196) | -1.319% | (3,830,119) | (3,685,525) | (3,649,604) | (3,772,342) |
| Gross Profit | 793,616 | -0.728% | 1,692,555 | 1,637,208 | 1,625,986 | 1,629,970 |
| 2025/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 479 | 217.219% | 148 | 333 | 24 | 1,205 | |
| Profit / (Loss) before Taxation | (134,853) | -- | (91,482) | 68,584 | 204,864 | 238,239 | |
| Taxation | (15,984) | 300.301% | (35,072) | (51,334) | (72,912) | (75,438) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 11 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (150,837) | -- | (126,554) | 17,250 | 131,963 | 162,801 | |
| 2025/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | |
| Net Finance Costs / (Income) | 132,809 | -18.831% | 323,289 | 309,246 | 157,317 | 96,398 |
| Depreciation & Amortisation | 42,990 | -7.029% | 245,158 | 233,741 | 230,914 | 246,884 |
| Directors' Emoluments | -- | -- | 33,619 | 25,957 | 25,588 | 24,831 |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | -1.570 | -- | -1.320 | 0.180 | 1.370 | 1.690 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.800 | 1.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | 58.394% | 59.172% |
| Cash flow per share ($) | -- | -- | 0.037 | 0.053 | 0.038 | 0.044 |
| NBV per share ($) | 0.380 | -- | 0.365 | 0.436 | 0.433 | 0.469 |
| Remarks: | Real time quote last updated: 29/08/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD -150,837 |
| %Change | -- |
| EPS / (LPS) | HKD -0.016 |
| NBV Per Share ($) | HKD 0.380 |